DE69217031T2 - Verapamiltablette mit kontrollierter freisetzung - Google Patents
Verapamiltablette mit kontrollierter freisetzungInfo
- Publication number
- DE69217031T2 DE69217031T2 DE69217031T DE69217031T DE69217031T2 DE 69217031 T2 DE69217031 T2 DE 69217031T2 DE 69217031 T DE69217031 T DE 69217031T DE 69217031 T DE69217031 T DE 69217031T DE 69217031 T2 DE69217031 T2 DE 69217031T2
- Authority
- DE
- Germany
- Prior art keywords
- controlled release
- verapamil
- tablet
- verapamil tablet
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Separation By Low-Temperature Treatments (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Plant Substances (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/736,031 US5169639A (en) | 1988-09-19 | 1991-07-25 | Controlled release verapamil tablets |
PCT/US1992/005712 WO1993001803A1 (en) | 1991-07-25 | 1992-07-02 | Controlled release verapamil tablet |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69217031D1 DE69217031D1 (de) | 1997-03-06 |
DE69217031T2 true DE69217031T2 (de) | 1997-05-07 |
Family
ID=24958214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69217031T Expired - Fee Related DE69217031T2 (de) | 1991-07-25 | 1992-07-02 | Verapamiltablette mit kontrollierter freisetzung |
Country Status (17)
Country | Link |
---|---|
US (1) | US5169639A (de) |
EP (1) | EP0550737B1 (de) |
JP (1) | JPH0733339B2 (de) |
KR (1) | KR0184308B1 (de) |
AT (1) | ATE147974T1 (de) |
AU (1) | AU649163B2 (de) |
CA (1) | CA2092287C (de) |
DE (1) | DE69217031T2 (de) |
DK (1) | DK0550737T3 (de) |
ES (1) | ES2099273T3 (de) |
FI (1) | FI107231B (de) |
GR (1) | GR3023086T3 (de) |
HU (1) | HU218658B (de) |
IE (1) | IE922411A1 (de) |
IL (1) | IL102614A (de) |
MX (1) | MX9204352A (de) |
WO (1) | WO1993001803A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5472711A (en) * | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
US5330761A (en) * | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
US5993860A (en) * | 1993-06-17 | 1999-11-30 | Venture Lending | NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants |
JP2527132B2 (ja) * | 1993-08-25 | 1996-08-21 | 清水化学株式会社 | 親水性多糖類よりなる外用薬組成物 |
US6726930B1 (en) * | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US5399358A (en) * | 1993-11-12 | 1995-03-21 | Edward Mendell Co., Inc. | Sustained release formulations for 24 hour release of metroprolol |
US5399359A (en) * | 1994-03-04 | 1995-03-21 | Edward Mendell Co., Inc. | Controlled release oxybutynin formulations |
CA2164513C (en) * | 1994-04-25 | 1999-09-21 | Anand R. Baichwal | Sustained release excipient |
US5399362A (en) * | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
AU7994694A (en) * | 1994-10-21 | 1996-05-15 | Leiras Oy | Controlled release oral delivery system containing oxybutynin |
WO1996016638A1 (en) * | 1994-12-01 | 1996-06-06 | Cibus Pharmaceutical, Inc. | Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
FR2729857B1 (fr) | 1995-01-27 | 1997-04-04 | Rhone Poulenc Chimie | Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire |
US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
US6083532A (en) * | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
AU2068797A (en) * | 1996-01-29 | 1997-08-20 | Edward Mendell Co. Inc. | Sustained release excipient |
AU3205497A (en) * | 1996-05-23 | 1997-12-09 | G.D. Searle & Co. | Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil |
JP3148256B2 (ja) | 1996-07-08 | 2001-03-19 | エドワード メンデル カンパニー.,インコーポレーテッド | 高用量難溶性薬物用持続放出マトリックス |
IN186245B (de) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US6056977A (en) | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
JP2002531491A (ja) * | 1998-12-11 | 2002-09-24 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | ヒドロコロイドおよびセルロースエーテルを含む持続放出性錠剤 |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
GB9910212D0 (en) * | 1999-05-05 | 1999-06-30 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
DE60038536T2 (de) * | 1999-09-30 | 2009-06-10 | Penwest Pharmaceuticals Co. | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
BR0115585A (pt) | 2000-11-28 | 2005-12-13 | Fmc Corp | Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento |
US20030190360A1 (en) | 2001-03-13 | 2003-10-09 | Baichwal Anand R. | Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment |
EP1245227A1 (de) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials |
CN1610551A (zh) | 2001-07-06 | 2005-04-27 | 恩德制药公司 | 用作止痛剂的6-羟基羟吗啡酮的肠胃外给药 |
AU2003230805A1 (en) * | 2002-04-05 | 2003-10-27 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
US20040005359A1 (en) * | 2002-06-27 | 2004-01-08 | Cheng Xiu Xiu | Controlled release oral dosage form |
EP1549296A4 (de) * | 2002-08-02 | 2006-08-09 | Penwest Pharmaceuticals Co | Metformin-formulierungen mit verzögerter freisetzung |
NZ545921A (en) | 2003-09-19 | 2009-09-25 | Penwest Pharmaceuticals Co | Delayed released dosage forms |
CN101578096A (zh) * | 2006-10-10 | 2009-11-11 | 潘威斯脱药物公司 | 稳健的缓释制剂 |
JP5463537B2 (ja) * | 2008-02-22 | 2014-04-09 | HOYA Technosurgical株式会社 | 分離方法 |
US20100159001A1 (en) * | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
US20100160363A1 (en) * | 2008-12-19 | 2010-06-24 | Aaipharma Services Corp. | Extended-release pharmaceutical formulations |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2993836A (en) * | 1958-02-20 | 1961-07-25 | Dow Chemical Co | Sustained release tablets |
US3079303A (en) * | 1958-12-11 | 1963-02-26 | Smith Kline French Lab | Basic tablet granulation and process of using same |
NL265428A (de) * | 1960-06-06 | |||
US3133863A (en) * | 1961-03-10 | 1964-05-19 | Strong Cobb Arner Inc | Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums |
US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
US3388041A (en) * | 1964-01-27 | 1968-06-11 | Richardson Merrell Inc | High dosage sustained release tablet |
GB1097207A (en) * | 1964-08-24 | 1967-12-29 | Collett & Co As | Process for the preparation of sustained action tablets |
US3456049A (en) * | 1965-05-25 | 1969-07-15 | Ciba Geigy Corp | Gradual-release tablet |
US3726690A (en) * | 1965-10-22 | 1973-04-10 | Kelco Co | Acidified food products containing xanthomonas colloid |
US3864469A (en) * | 1967-12-16 | 1975-02-04 | Hoechst Ag | Xanthines in pharmaceutical preparations and for stabilization of vitamins |
US3627583A (en) * | 1969-04-29 | 1971-12-14 | Sucrest Corp | Direct compression vehicles |
US3639169A (en) * | 1969-04-29 | 1972-02-01 | Sucrest Corp | Direct compression vehicles and method therefor |
US3629393A (en) * | 1969-09-11 | 1971-12-21 | Nikken Chemicals Co Ltd | Release-sustaining-tablet |
GB1359643A (en) * | 1970-09-28 | 1974-07-10 | Controlled Medications | Controlled release medicament |
US4072535A (en) * | 1970-12-28 | 1978-02-07 | A. E. Staley Manufacturing Company | Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules |
US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
US3836618A (en) * | 1971-12-23 | 1974-09-17 | American Home Prod | Process for the uniform distribution of a drug on a granulated base |
FR2183546B1 (de) * | 1972-05-10 | 1975-06-20 | Servier Lab | |
US3963832A (en) * | 1973-01-24 | 1976-06-15 | Teijin Limited | Liquid or pasty dentifrice and process for its preparation |
US3809294A (en) * | 1973-06-27 | 1974-05-07 | American Cyanamid Co | Dispensing lung contacting powdered medicaments |
US4013820A (en) * | 1974-11-07 | 1977-03-22 | Abbott Laboratories | Universally useable tableting ingredients |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
DE2732201C2 (de) * | 1977-07-16 | 1983-01-13 | Messerschmitt-Bölkow-Blohm GmbH, 8000 München | Regler für die Lagestabilisierung eines Satelliten |
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
US4361545A (en) * | 1979-05-21 | 1982-11-30 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion |
US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
US4308251A (en) * | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
US4439453A (en) * | 1980-12-22 | 1984-03-27 | Monsanto Company | Directly compressible acetaminophen granulation |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
US4424235A (en) * | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
US4525345A (en) * | 1981-12-24 | 1985-06-25 | Verex Laboratories, Inc. | Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4556678A (en) * | 1982-06-24 | 1985-12-03 | Key Pharmaceuticals, Inc. | Sustained release propranolol tablet |
US4698264A (en) * | 1982-08-02 | 1987-10-06 | Durkee Industrial Foods, Corp. | Particulate composition and process for making same |
US4698101A (en) * | 1982-08-30 | 1987-10-06 | Suomen Sokeri Oy (Finnish Sugar Company Ltd.) | Binder-diluent composition and method |
DE3435325A1 (de) * | 1983-04-09 | 1986-04-17 | Nikken Chemicals Co., Ltd., Tokio/Tokyo | Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung |
US4717713A (en) * | 1983-10-31 | 1988-01-05 | Research Corporation | Controlled release liquid pharmaceutical |
JPS60219238A (ja) * | 1984-04-14 | 1985-11-01 | Hayashibara Biochem Lab Inc | 徐崩性プルラン含有成形物とその製法 |
US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
JPS6124516A (ja) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | 持続性錠剤 |
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
DE3440288A1 (de) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung |
US4695463A (en) * | 1985-05-24 | 1987-09-22 | Warner-Lambert Company | Delivery system for active ingredients and preparation thereof |
EP0227814A1 (de) * | 1985-07-02 | 1987-07-08 | The Upjohn Company | Therapeutische zusammensetzungen mit bimodalabgabe-charakteristiken |
GB8518927D0 (en) * | 1985-07-26 | 1985-09-04 | Vincent Processes Ltd | Tablets |
GB8522453D0 (en) * | 1985-09-11 | 1985-10-16 | Lilly Industries Ltd | Chewable capsules |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
IT1191674B (it) * | 1986-03-07 | 1988-03-23 | Eurand Spa | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale |
US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
GB8608818D0 (en) * | 1986-04-11 | 1986-05-14 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
GB8613689D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
JPH0826346B2 (ja) * | 1986-07-10 | 1996-03-13 | 株式会社林原生物化学研究所 | 固状油溶性物質の製法 |
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
ES2045281T3 (es) * | 1988-07-13 | 1994-01-16 | Knoll Ag | Forma de medicamento de accion retardada sobre la base de alginatos. |
GB8908647D0 (en) * | 1989-04-17 | 1989-06-01 | Glaxo Group Ltd | Device |
-
1991
- 1991-07-25 US US07/736,031 patent/US5169639A/en not_active Expired - Lifetime
-
1992
- 1992-07-02 WO PCT/US1992/005712 patent/WO1993001803A1/en active IP Right Grant
- 1992-07-02 KR KR1019930700917A patent/KR0184308B1/ko not_active IP Right Cessation
- 1992-07-02 CA CA002092287A patent/CA2092287C/en not_active Expired - Fee Related
- 1992-07-02 EP EP92916803A patent/EP0550737B1/de not_active Expired - Lifetime
- 1992-07-02 AU AU24033/92A patent/AU649163B2/en not_active Ceased
- 1992-07-02 AT AT92916803T patent/ATE147974T1/de not_active IP Right Cessation
- 1992-07-02 DK DK92916803.7T patent/DK0550737T3/da active
- 1992-07-02 ES ES92916803T patent/ES2099273T3/es not_active Expired - Lifetime
- 1992-07-02 DE DE69217031T patent/DE69217031T2/de not_active Expired - Fee Related
- 1992-07-02 JP JP5502844A patent/JPH0733339B2/ja not_active Expired - Fee Related
- 1992-07-02 HU HU9300768A patent/HU218658B/hu not_active IP Right Cessation
- 1992-07-23 IL IL10261492A patent/IL102614A/xx not_active IP Right Cessation
- 1992-07-24 MX MX9204352A patent/MX9204352A/es not_active IP Right Cessation
- 1992-07-24 IE IE241192A patent/IE922411A1/en not_active IP Right Cessation
-
1993
- 1993-03-25 FI FI931342A patent/FI107231B/fi active
-
1997
- 1997-04-09 GR GR970400758T patent/GR3023086T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0550737A1 (de) | 1993-07-14 |
JPH0733339B2 (ja) | 1995-04-12 |
EP0550737B1 (de) | 1997-01-22 |
HU218658B (hu) | 2000-10-28 |
IL102614A0 (en) | 1993-01-14 |
JPH06500576A (ja) | 1994-01-20 |
FI107231B (fi) | 2001-06-29 |
ATE147974T1 (de) | 1997-02-15 |
FI931342A (fi) | 1993-03-25 |
CA2092287C (en) | 1997-03-25 |
DE69217031D1 (de) | 1997-03-06 |
IL102614A (en) | 1997-02-18 |
KR930701983A (ko) | 1993-09-08 |
EP0550737A4 (en) | 1993-12-15 |
AU2403392A (en) | 1993-02-23 |
MX9204352A (es) | 1993-04-01 |
WO1993001803A1 (en) | 1993-02-04 |
ES2099273T3 (es) | 1997-05-16 |
US5169639A (en) | 1992-12-08 |
HU9300768D0 (en) | 1993-06-28 |
KR0184308B1 (ko) | 1999-05-01 |
DK0550737T3 (de) | 1997-02-17 |
FI931342A0 (fi) | 1993-03-25 |
HUT64221A (en) | 1993-12-28 |
GR3023086T3 (en) | 1997-07-30 |
AU649163B2 (en) | 1994-05-12 |
IE922411A1 (en) | 1993-01-27 |
CA2092287A1 (en) | 1993-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69217031T2 (de) | Verapamiltablette mit kontrollierter freisetzung | |
DE3583072D1 (de) | Tablette mit verzoegerter freisetzung. | |
DE3778356D1 (de) | Boriertes ueberbasisches material. | |
ATE71837T1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
IT8820145A0 (it) | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. | |
IT1216735B (it) | Prodotto terapeutico a base di derivati organici del silicio. | |
NO860867L (no) | Materiale som er anvendelig som farmasoeylisk eksipient, samt fremgangsmaate for fremstilling av et slikt. | |
NO923746L (no) | Blanding inneholdende vekstfaktorer og polyelektrolytter,fremgangsmaate for fremstilling derav, samt farmasoeytisk preparat som inneholder blandingen | |
NO882562D0 (no) | Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav. | |
FI894121A (fi) | 2-atsa-4-(alkoksikarbonyyli)spiro/4,5/dekan-3-oni | |
DE59001121D1 (en) | Antacidatabletten. | |
ES2021579B3 (es) | Capsulas divisibles en piezas | |
DE3767291D1 (de) | Presse, die mit ihrem unterbau vertikal federnd abgestuetzt ist. | |
DE3483850D1 (de) | Tablette mit kontrollierter freigabe. | |
NO180450C (no) | Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin | |
ATE127690T1 (de) | Niedrigdosiertes aspirin mit gesteuerter freigabe. | |
EP0429324A3 (en) | Use of n-methyl-2-(3-pyridyl)2-tetrahydrothiopyran-carbothioamide-1-oxide for the preparation of medicaments for the treatment of coronary insufficiency | |
DK101781A (da) | Fremgangsmaade til fremstilling af 10/substituerede 5-cyamethylen-dibenzo (a,d) cycloheptener | |
ITFI910264A1 (it) | Procedimento per la produzione di un bollino farmaceutico od equivalente, e bollino cosi' realizzato | |
IT1241478B (it) | Composizioni farmaceutiche a base di calcitonina, somministrabili per via endonasale, per il controllo del calcio sierico e del dismetabolismo osseo. | |
DK165918C (da) | 4-phenylpiperidinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne | |
DE58900047D1 (de) | Wirbelschichtapparatur, insbesondere zum granulieren pulverfoermiger substanz. | |
ES1007624Y (es) | Dispositivo para el accionamiento de la pinza tramadora de telares. | |
NO885065D0 (no) | Fremgangsmÿte for ÿ krystallisere termoplastmateriale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PENWEST PHARMACEUTICALS CO., PATTERSON, N.Y., US |
|
8339 | Ceased/non-payment of the annual fee |